Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics and consumer health products. The Company's oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products.

Current Report (Form 8-K | Period ending 2024-11-05)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Catalent Inc (CTLT US)

Current Report (Form 8-K | Period ending 2024-11-05)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Annual Report (Amendment) (Form 10-K/A | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-10-21)

Annual Report (Form 10-K | Period ending 2024-06-30)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)